Predicted protein targets (top 1)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CTSA | P10619 | 20/20 | 0.66 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL14662643 | 1.00 | CTSA (0.66) | CTSA | |
| SCHEMBL12498200 | 0.80 | CTSA (1.00) | CTSA | |
| SCHEMBL12498526 | 0.80 | CTSA (1.00) | CTSA | |
| SCHEMBL12498193 | 0.80 | CTSA (1.00) | CTSA | |
| SCHEMBL12498529 | 0.80 | CTSA (1.00) | CTSA | |
| SCHEMBL15635947 | 0.78 | CTSA (1.00) | CTSA | |
| SCHEMBL15635946 | 0.78 | CTSA (1.00) | CTSA | |
| SCHEMBL15636385 | 0.78 | CTSA (1.00) | CTSA | |
| SCHEMBL15636387 | 0.78 | CTSA (1.00) | CTSA | |
| SCHEMBL14662064 | 0.78 | CTSA (0.66) | CTSA |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 10 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20160237060-A1 | 3-HETEROAROYLAMINO-PROPIONIC ACID DERIVATIVES AND THEIR USE AS PHARMACEUTICALS | SANOFI (FR) | 2016-08-18 | — | — | US | claimed |
| CN-103827097-A | 3-heteroaroylamino-propionic acid derivatives and their use as pharmaceuticals | SANOFI SA | 2014-05-28 | — | — | CN | claimed |
| US-20130053416-A1 | 3-HETEROAROYLAMINO-PROPIONIC ACID DERIVATIVES AND THEIR USE AS PHARMACEUTICALS | SANOFI (FR) | 2013-02-28 | — | — | US | claimed |
| CN-105646362-B | 3- heteroaroylamino-propanoic derivatives and its purposes as drug | 赛诺菲 | 2019-07-05 | — | — | CN | disclosed |
| US-9751858-B2 | 3-heteroaroylamino-propionic acid derivatives and their use as pharmaceuticals | SANOFI (FR) | 2017-09-05 | — | — | US | disclosed |
| US-20160237060-A1 | 3-HETEROAROYLAMINO-PROPIONIC ACID DERIVATIVES AND THEIR USE AS PHARMACEUTICALS | SANOFI (FR) | 2016-08-18 | — | — | US | disclosed |
| US-9353068-B2 | 3-heteroaroylamino-propionic acid derivatives and their use as pharmaceuticals | SANOFI (FR) | 2016-05-31 | — | — | US | disclosed |
| CN-103827097-B | 3-heteroaroylamino-propionic acid derivatives and their use as pharmaceuticals | SAI NUOFEI (FR) | 2016-03-16 | — | — | CN | disclosed |
| CN-103827097-A | 3-heteroaroylamino-propionic acid derivatives and their use as pharmaceuticals | SANOFI SA | 2014-05-28 | — | — | CN | disclosed |
| US-20130053416-A1 | 3-HETEROAROYLAMINO-PROPIONIC ACID DERIVATIVES AND THEIR USE AS PHARMACEUTICALS | SANOFI (FR) | 2013-02-28 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20160237060-A1 | 3-HETEROAROYLAMINO-PROPIONIC ACID DERIVATIVES AND THEIR USE AS PHARMACEUTICALS | CTSF, CTSS, CTSV | CTSA 11/4885 |
| US-20130053416-A1 | 3-HETEROAROYLAMINO-PROPIONIC ACID DERIVATIVES AND THEIR USE AS PHARMACEUTICALS | CTSF, CTSS, CTSV | CTSA 10/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.